SOURCE: http://collegestock.com/blog/bcrx-the-de...

If you haven’t noticed lately, Swine Flu (H1N1) is like Ron Burgundy, “Kind of a BIG Deal.”

This is why The Dean taught the CollegeStock Community about BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) as part of The Dean’s Prerequisite Picks this week.

As the weather’s getting colder, The Dean’s warming up and gradually teaching all of his students about swine flu because The Dean’s upcoming swine flu stock is not only an FDA-Approved Ivy League Stock Pick but also an IPO.

$BCRX is The Dean’s barometer for the swine flu epidemic and this stock has been up as much as 33% so far this week and 40% over the past month.

The winter cold and December flu season is approaching and The Dean can see the pressure building in swine flu stocks like $BCRX.

This week, $BCRX received a $22.5 million order of their intravenous (IV) flu drug Peramivir and what’s potentially even bigger than that is this only bought the U.S. Government 10,000 treatments.

The Dean watched $BCRX jump more than 30% on this news—just imagine what the second order of 120,000 treatments, or $270 million worth, will do to this swine flu stock.

The Dean believes that the demand for flu-related treatments and therapies will be greater this year than ever before so do your homework, Register for Honors Class and move to the Head of the Class with The Dean this flu season.